Evogene Reports Fourth Quarter and Full Year 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Evogene (EVGN) Misses Q4 EPS by 5c
March 1, 2016 7:09 AM ESTEvogene (NYSE: EVGN) reported Q4 EPS of ($0.22), $0.05 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $2.46 million versus the consensus estimate of $3.9 million.
For earnings history and earnings-related data on Evogene (EVGN) click here.
... More


